Cancer Genome Market Size, Share 2022

TABLE OF CONTENTS

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cancer Genome Analysis Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Solid Tissue Analysis
1.2.3 Liquid Tissue Analysis
1.3 Market by Application
1.3.1 Global Cancer Genome Analysis Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Clinical
1.3.3 Pharmaceutical
1.3.4 Research
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Cancer Genome Analysis Market Perspective (2017-2028)
2.2 Cancer Genome Analysis Growth Trends by Region
2.2.1 Cancer Genome Analysis Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Cancer Genome Analysis Historic Market Size by Region (2017-2022)
2.2.3 Cancer Genome Analysis Forecasted Market Size by Region (2023-2028)
2.3 Cancer Genome Analysis Market Dynamics
2.3.1 Cancer Genome Analysis Industry Trends
2.3.2 Cancer Genome Analysis Market Drivers
2.3.3 Cancer Genome Analysis Market Challenges
2.3.4 Cancer Genome Analysis Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cancer Genome Analysis Players by Revenue
3.1.1 Global Top Cancer Genome Analysis Players by Revenue (2017-2022)
3.1.2 Global Cancer Genome Analysis Revenue Market Share by Players (2017-2022)
3.2 Global Cancer Genome Analysis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cancer Genome Analysis Revenue
3.4 Global Cancer Genome Analysis Market Concentration Ratio
3.4.1 Global Cancer Genome Analysis Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cancer Genome Analysis Revenue in 2021
3.5 Cancer Genome Analysis Key Players Head office and Area Served
3.6 Key Players Cancer Genome Analysis Product Solution and Service
3.7 Date of Enter into Cancer Genome Analysis Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cancer Genome Analysis Breakdown Data by Type
4.1 Global Cancer Genome Analysis Historic Market Size by Type (2017-2022)
4.2 Global Cancer Genome Analysis Forecasted Market Size by Type (2023-2028)
5 Cancer Genome Analysis Breakdown Data by Application
5.1 Global Cancer Genome Analysis Historic Market Size by Application (2017-2022)
5.2 Global Cancer Genome Analysis Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Cancer Genome Analysis Market Size (2017-2028)
6.2 North America Cancer Genome Analysis Market Size by Type
6.2.1 North America Cancer Genome Analysis Market Size by Type (2017-2022)
6.2.2 North America Cancer Genome Analysis Market Size by Type (2023-2028)
6.2.3 North America Cancer Genome Analysis Market Share by Type (2017-2028)
6.3 North America Cancer Genome Analysis Market Size by Application
6.3.1 North America Cancer Genome Analysis Market Size by Application (2017-2022)
6.3.2 North America Cancer Genome Analysis Market Size by Application (2023-2028)
6.3.3 North America Cancer Genome Analysis Market Share by Application (2017-2028)
6.4 North America Cancer Genome Analysis Market Size by Country
6.4.1 North America Cancer Genome Analysis Market Size by Country (2017-2022)
6.4.2 North America Cancer Genome Analysis Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Cancer Genome Analysis Market Size (2017-2028)
7.2 Europe Cancer Genome Analysis Market Size by Type
7.2.1 Europe Cancer Genome Analysis Market Size by Type (2017-2022)
7.2.2 Europe Cancer Genome Analysis Market Size by Type (2023-2028)
7.2.3 Europe Cancer Genome Analysis Market Share by Type (2017-2028)
7.3 Europe Cancer Genome Analysis Market Size by Application
7.3.1 Europe Cancer Genome Analysis Market Size by Application (2017-2022)
7.3.2 Europe Cancer Genome Analysis Market Size by Application (2023-2028)
7.3.3 Europe Cancer Genome Analysis Market Share by Application (2017-2028)
7.4 Europe Cancer Genome Analysis Market Size by Country
7.4.1 Europe Cancer Genome Analysis Market Size by Country (2017-2022)
7.4.2 Europe Cancer Genome Analysis Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cancer Genome Analysis Market Size (2017-2028)
8.2 Asia-Pacific Cancer Genome Analysis Market Size by Type
8.2.1 Asia-Pacific Cancer Genome Analysis Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Cancer Genome Analysis Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Cancer Genome Analysis Market Share by Type (2017-2028)
8.3 Asia-Pacific Cancer Genome Analysis Market Size by Application
8.3.1 Asia-Pacific Cancer Genome Analysis Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Cancer Genome Analysis Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Cancer Genome Analysis Market Share by Application (2017-2028)
8.4 Asia-Pacific Cancer Genome Analysis Market Size by Region
8.4.1 Asia-Pacific Cancer Genome Analysis Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Cancer Genome Analysis Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Cancer Genome Analysis Market Size (2017-2028)
9.2 Latin America Cancer Genome Analysis Market Size by Type
9.2.1 Latin America Cancer Genome Analysis Market Size by Type (2017-2022)
9.2.2 Latin America Cancer Genome Analysis Market Size by Type (2023-2028)
9.2.3 Latin America Cancer Genome Analysis Market Share by Type (2017-2028)
9.3 Latin America Cancer Genome Analysis Market Size by Application
9.3.1 Latin America Cancer Genome Analysis Market Size by Application (2017-2022)
9.3.2 Latin America Cancer Genome Analysis Market Size by Application (2023-2028)
9.3.3 Latin America Cancer Genome Analysis Market Share by Application (2017-2028)
9.4 Latin America Cancer Genome Analysis Market Size by Country
9.4.1 Latin America Cancer Genome Analysis Market Size by Country (2017-2022)
9.4.2 Latin America Cancer Genome Analysis Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cancer Genome Analysis Market Size (2017-2028)
10.2 Middle East & Africa Cancer Genome Analysis Market Size by Type
10.2.1 Middle East & Africa Cancer Genome Analysis Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Cancer Genome Analysis Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Cancer Genome Analysis Market Share by Type (2017-2028)
10.3 Middle East & Africa Cancer Genome Analysis Market Size by Application
10.3.1 Middle East & Africa Cancer Genome Analysis Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Cancer Genome Analysis Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Cancer Genome Analysis Market Share by Application (2017-2028)
10.4 Middle East & Africa Cancer Genome Analysis Market Size by Country
10.4.1 Middle East & Africa Cancer Genome Analysis Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Cancer Genome Analysis Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Abbott Diagnostics
11.1.1 Abbott Diagnostics Company Details
11.1.2 Abbott Diagnostics Business Overview
11.1.3 Abbott Diagnostics Cancer Genome Analysis Introduction
11.1.4 Abbott Diagnostics Revenue in Cancer Genome Analysis Business (2017-2022)
11.1.5 Abbott Diagnostics Recent Developments
11.2 AccuraGen Inc
11.2.1 AccuraGen Inc Company Details
11.2.2 AccuraGen Inc Business Overview
11.2.3 AccuraGen Inc Cancer Genome Analysis Introduction
11.2.4 AccuraGen Inc Revenue in Cancer Genome Analysis Business (2017-2022)
11.2.5 AccuraGen Inc Recent Developments
11.3 Acuamark Diagnostics
11.3.1 Acuamark Diagnostics Company Details
11.3.2 Acuamark Diagnostics Business Overview
11.3.3 Acuamark Diagnostics Cancer Genome Analysis Introduction
11.3.4 Acuamark Diagnostics Revenue in Cancer Genome Analysis Business (2017-2022)
11.3.5 Acuamark Diagnostics Recent Developments
11.4 Admera Health, LLC
11.4.1 Admera Health, LLC Company Details
11.4.2 Admera Health, LLC Business Overview
11.4.3 Admera Health, LLC Cancer Genome Analysis Introduction
11.4.4 Admera Health, LLC Revenue in Cancer Genome Analysis Business (2017-2022)
11.4.5 Admera Health, LLC Recent Developments
11.5 Agena Bioscience, Inc
11.5.1 Agena Bioscience, Inc Company Details
11.5.2 Agena Bioscience, Inc Business Overview
11.5.3 Agena Bioscience, Inc Cancer Genome Analysis Introduction
11.5.4 Agena Bioscience, Inc Revenue in Cancer Genome Analysis Business (2017-2022)
11.5.5 Agena Bioscience, Inc Recent Developments
11.6 Agilent
11.6.1 Agilent Company Details
11.6.2 Agilent Business Overview
11.6.3 Agilent Cancer Genome Analysis Introduction
11.6.4 Agilent Revenue in Cancer Genome Analysis Business (2017-2022)
11.6.5 Agilent Recent Developments
11.7 Almac Diagnostics
11.7.1 Almac Diagnostics Company Details
11.7.2 Almac Diagnostics Business Overview
11.7.3 Almac Diagnostics Cancer Genome Analysis Introduction
11.7.4 Almac Diagnostics Revenue in Cancer Genome Analysis Business (2017-2022)
11.7.5 Almac Diagnostics Recent Developments
11.8 Amoy Diagnostics Co., Ltd.
11.8.1 Amoy Diagnostics Co., Ltd. Company Details
11.8.2 Amoy Diagnostics Co., Ltd. Business Overview
11.8.3 Amoy Diagnostics Co., Ltd. Cancer Genome Analysis Introduction
11.8.4 Amoy Diagnostics Co., Ltd. Revenue in Cancer Genome Analysis Business (2017-2022)
11.8.5 Amoy Diagnostics Co., Ltd. Recent Developments
11.9 Anchor Dx
11.9.1 Anchor Dx Company Details
11.9.2 Anchor Dx Business Overview
11.9.3 Anchor Dx Cancer Genome Analysis Introduction
11.9.4 Anchor Dx Revenue in Cancer Genome Analysis Business (2017-2022)
11.9.5 Anchor Dx Recent Developments
11.10 ANGLE plc
11.10.1 ANGLE plc Company Details
11.10.2 ANGLE plc Business Overview
11.10.3 ANGLE plc Cancer Genome Analysis Introduction
11.10.4 ANGLE plc Revenue in Cancer Genome Analysis Business (2017-2022)
11.10.5 ANGLE plc Recent Developments
11.11 ApoCell, Inc.
11.11.1 ApoCell, Inc. Company Details
11.11.2 ApoCell, Inc. Business Overview
11.11.3 ApoCell, Inc. Cancer Genome Analysis Introduction
11.11.4 ApoCell, Inc. Revenue in Cancer Genome Analysis Business (2017-2022)
11.11.5 ApoCell, Inc. Recent Developments
11.12 ArcherDx, Inc
11.12.1 ArcherDx, Inc Company Details
11.12.2 ArcherDx, Inc Business Overview
11.12.3 ArcherDx, Inc Cancer Genome Analysis Introduction
11.12.4 ArcherDx, Inc Revenue in Cancer Genome Analysis Business (2017-2022)
11.12.5 ArcherDx, Inc Recent Developments
11.13 Asuragen
11.13.1 Asuragen Company Details
11.13.2 Asuragen Business Overview
11.13.3 Asuragen Cancer Genome Analysis Introduction
11.13.4 Asuragen Revenue in Cancer Genome Analysis Business (2017-2022)
11.13.5 Asuragen Recent Developments
11.14 AVIVA Biosciences
11.14.1 AVIVA Biosciences Company Details
11.14.2 AVIVA Biosciences Business Overview
11.14.3 AVIVA Biosciences Cancer Genome Analysis Introduction
11.14.4 AVIVA Biosciences Revenue in Cancer Genome Analysis Business (2017-2022)
11.14.5 AVIVA Biosciences Recent Developments
11.15 Baylor Miraca Genetics Laboratories
11.15.1 Baylor Miraca Genetics Laboratories Company Details
11.15.2 Baylor Miraca Genetics Laboratories Business Overview
11.15.3 Baylor Miraca Genetics Laboratories Cancer Genome Analysis Introduction
11.15.4 Baylor Miraca Genetics Laboratories Revenue in Cancer Genome Analysis Business (2017-2022)
11.15.5 Baylor Miraca Genetics Laboratories Recent Developments
11.16 Beckman Coulter, Inc.
11.16.1 Beckman Coulter, Inc. Company Details
11.16.2 Beckman Coulter, Inc. Business Overview
11.16.3 Beckman Coulter, Inc. Cancer Genome Analysis Introduction
11.16.4 Beckman Coulter, Inc. Revenue in Cancer Genome Analysis Business (2017-2022)
11.16.5 Beckman Coulter, Inc. Recent Developments
11.17 Becton, Dickinson and Company
11.17.1 Becton, Dickinson and Company Company Details
11.17.2 Becton, Dickinson and Company Business Overview
11.17.3 Becton, Dickinson and Company Cancer Genome Analysis Introduction
11.17.4 Becton, Dickinson and Company Revenue in Cancer Genome Analysis Business (2017-2022)
11.17.5 Becton, Dickinson and Company Recent Developments
11.18 BGI Genomics Co. Ltd
11.18.1 BGI Genomics Co. Ltd Company Details
11.18.2 BGI Genomics Co. Ltd Business Overview
11.18.3 BGI Genomics Co. Ltd Cancer Genome Analysis Introduction
11.18.4 BGI Genomics Co. Ltd Revenue in Cancer Genome Analysis Business (2017-2022)
11.18.5 BGI Genomics Co. Ltd Recent Developments
11.19 Bioarray Genetics
11.19.1 Bioarray Genetics Company Details
11.19.2 Bioarray Genetics Business Overview
11.19.3 Bioarray Genetics Cancer Genome Analysis Introduction
11.19.4 Bioarray Genetics Revenue in Cancer Genome Analysis Business (2017-2022)
11.19.5 Bioarray Genetics Recent Developments
11.20 Biocartis
11.20.1 Biocartis Company Details
11.20.2 Biocartis Business Overview
11.20.3 Biocartis Cancer Genome Analysis Introduction
11.20.4 Biocartis Revenue in Cancer Genome Analysis Business (2017-2022)
11.20.5 Biocartis Recent Developments
11.21 Biocept, Inc
11.21.1 Biocept, Inc Company Details
11.21.2 Biocept, Inc Business Overview
11.21.3 Biocept, Inc Cancer Genome Analysis Introduction
11.21.4 Biocept, Inc Revenue in Cancer Genome Analysis Business (2017-2022)
11.21.5 Biocept, Inc Recent Developments
11.22 Biodesix Inc
11.22.1 Biodesix Inc Company Details
11.22.2 Biodesix Inc Business Overview
11.22.3 Biodesix Inc Cancer Genome Analysis Introduction
11.22.4 Biodesix Inc Revenue in Cancer Genome Analysis Business (2017-2022)
11.22.5 Biodesix Inc Recent Developments
11.23 BioFluidica
11.23.1 BioFluidica Company Details
11.23.2 BioFluidica Business Overview
11.23.3 BioFluidica Cancer Genome Analysis Introduction
11.23.4 BioFluidica Revenue in Cancer Genome Analysis Business (2017-2022)
11.23.5 BioFluidica Recent Developments
11.24 bioM?rieux Diagnostics
11.24.1 bioM?rieux Diagnostics Company Details
11.24.2 bioM?rieux Diagnostics Business Overview
11.24.3 bioM?rieux Diagnostics Cancer Genome Analysis Introduction
11.24.4 bioM?rieux Diagnostics Revenue in Cancer Genome Analysis Business (2017-2022)
11.24.5 bioM?rieux Diagnostics Recent Developments
11.25 Bioneer Corporation
11.25.1 Bioneer Corporation Company Details
11.25.2 Bioneer Corporation Business Overview
11.25.3 Bioneer Corporation Cancer Genome Analysis Introduction
11.25.4 Bioneer Corporation Revenue in Cancer Genome Analysis Business (2017-2022)
11.25.5 Bioneer Corporation Recent Developments
11.26 Bio-Rad Laboratories, Inc
11.26.1 Bio-Rad Laboratories, Inc Company Details
11.26.2 Bio-Rad Laboratories, Inc Business Overview
11.26.3 Bio-Rad Laboratories, Inc Cancer Genome Analysis Introduction
11.26.4 Bio-Rad Laboratories, Inc Revenue in Cancer Genome Analysis Business (2017-2022)
11.26.5 Bio-Rad Laboratories, Inc Recent Developments
11.27 Bio-Techne
11.27.1 Bio-Techne Company Details
11.27.2 Bio-Techne Business Overview
11.27.3 Bio-Techne Cancer Genome Analysis Introduction
11.27.4 Bio-Techne Revenue in Cancer Genome Analysis Business (2017-2022)
11.27.5 Bio-Techne Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

LIST OF TABLES & FIGURES

List of Tables
Table 1. Global Cancer Genome Analysis Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Solid Tissue Analysis
Table 3. Key Players of Liquid Tissue Analysis
Table 4. Global Cancer Genome Analysis Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 5. Global Cancer Genome Analysis Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Cancer Genome Analysis Market Size by Region (2017-2022) & (US$ Million)
Table 7. Global Cancer Genome Analysis Market Share by Region (2017-2022)
Table 8. Global Cancer Genome Analysis Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 9. Global Cancer Genome Analysis Market Share by Region (2023-2028)
Table 10. Cancer Genome Analysis Market Trends
Table 11. Cancer Genome Analysis Market Drivers
Table 12. Cancer Genome Analysis Market Challenges
Table 13. Cancer Genome Analysis Market Restraints
Table 14. Global Cancer Genome Analysis Revenue by Players (2017-2022) & (US$ Million)
Table 15. Global Cancer Genome Analysis Revenue Share by Players (2017-2022)
Table 16. Global Top Cancer Genome Analysis by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Genome Analysis as of 2021)
Table 17. Ranking of Global Top Cancer Genome Analysis Companies by Revenue (US$ Million) in 2021
Table 18. Global 5 Largest Players Market Share by Cancer Genome Analysis Revenue (CR5 and HHI) & (2017-2022)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Cancer Genome Analysis Product Solution and Service
Table 21. Date of Enter into Cancer Genome Analysis Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Cancer Genome Analysis Market Size by Type (2017-2022) & (US$ Million)
Table 24. Global Cancer Genome Analysis Revenue Market Share by Type (2017-2022)
Table 25. Global Cancer Genome Analysis Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 26. Global Cancer Genome Analysis Revenue Market Share by Type (2023-2028)
Table 27. Global Cancer Genome Analysis Market Size by Application (2017-2022) & (US$ Million)
Table 28. Global Cancer Genome Analysis Revenue Share by Application (2017-2022)
Table 29. Global Cancer Genome Analysis Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 30. Global Cancer Genome Analysis Revenue Share by Application (2023-2028)
Table 31. North America Cancer Genome Analysis Market Size by Type (2017-2022) & (US$ Million)
Table 32. North America Cancer Genome Analysis Market Size by Type (2023-2028) & (US$ Million)
Table 33. North America Cancer Genome Analysis Market Size by Application (2017-2022) & (US$ Million)
Table 34. North America Cancer Genome Analysis Market Size by Application (2023-2028) & (US$ Million)
Table 35. North America Cancer Genome Analysis Market Size by Country (2017-2022) & (US$ Million)
Table 36. North America Cancer Genome Analysis Market Size by Country (2023-2028) & (US$ Million)
Table 37. Europe Cancer Genome Analysis Market Size by Type (2017-2022) & (US$ Million)
Table 38. Europe Cancer Genome Analysis Market Size by Type (2023-2028) & (US$ Million)
Table 39. Europe Cancer Genome Analysis Market Size by Application (2017-2022) & (US$ Million)
Table 40. Europe Cancer Genome Analysis Market Size by Application (2023-2028) & (US$ Million)
Table 41. Europe Cancer Genome Analysis Market Size by Country (2017-2022) & (US$ Million)
Table 42. Europe Cancer Genome Analysis Market Size by Country (2023-2028) & (US$ Million)
Table 43. Asia Pacific Cancer Genome Analysis Market Size by Type (2017-2022) & (US$ Million)
Table 44. Asia Pacific Cancer Genome Analysis Market Size by Type (2023-2028) & (US$ Million)
Table 45. Asia Pacific Cancer Genome Analysis Market Size by Application (2017-2022) & (US$ Million)
Table 46. Asia Pacific Cancer Genome Analysis Market Size by Application (2023-2028) & (US$ Million)
Table 47. Asia Pacific Cancer Genome Analysis Market Size by Region (2017-2022) & (US$ Million)
Table 48. Asia Pacific Cancer Genome Analysis Market Size by Region (2023-2028) & (US$ Million)
Table 49. Latin America Cancer Genome Analysis Market Size by Type (2017-2022) & (US$ Million)
Table 50. Latin America Cancer Genome Analysis Market Size by Type (2023-2028) & (US$ Million)
Table 51. Latin America Cancer Genome Analysis Market Size by Application (2017-2022) & (US$ Million)
Table 52. Latin America Cancer Genome Analysis Market Size by Application (2023-2028) & (US$ Million)
Table 53. Latin America Cancer Genome Analysis Market Size by Country (2017-2022) & (US$ Million)
Table 54. Latin America Cancer Genome Analysis Market Size by Country (2023-2028) & (US$ Million)
Table 55. Middle East and Africa Cancer Genome Analysis Market Size by Type (2017-2022) & (US$ Million)
Table 56. Middle East and Africa Cancer Genome Analysis Market Size by Type (2023-2028) & (US$ Million)
Table 57. Middle East and Africa Cancer Genome Analysis Market Size by Application (2017-2022) & (US$ Million)
Table 58. Middle East and Africa Cancer Genome Analysis Market Size by Application (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Cancer Genome Analysis Market Size by Country (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Cancer Genome Analysis Market Size by Country (2023-2028) & (US$ Million)
Table 61. Abbott Diagnostics Company Details
Table 62. Abbott Diagnostics Business Overview
Table 63. Abbott Diagnostics Cancer Genome Analysis Product
Table 64. Abbott Diagnostics Revenue in Cancer Genome Analysis Business (2017-2022) & (US$ Million)
Table 65. Abbott Diagnostics Recent Developments
Table 66. AccuraGen Inc Company Details
Table 67. AccuraGen Inc Business Overview
Table 68. AccuraGen Inc Cancer Genome Analysis Product
Table 69. AccuraGen Inc Revenue in Cancer Genome Analysis Business (2017-2022) & (US$ Million)
Table 70. AccuraGen Inc Recent Developments
Table 71. Acuamark Diagnostics Company Details
Table 72. Acuamark Diagnostics Business Overview
Table 73. Acuamark Diagnostics Cancer Genome Analysis Product
Table 74. Acuamark Diagnostics Revenue in Cancer Genome Analysis Business (2017-2022) & (US$ Million)
Table 75. Acuamark Diagnostics Recent Developments
Table 76. Admera Health, LLC Company Details
Table 77. Admera Health, LLC Business Overview
Table 78. Admera Health, LLC Cancer Genome Analysis Product
Table 79. Admera Health, LLC Revenue in Cancer Genome Analysis Business (2017-2022) & (US$ Million)
Table 80. Admera Health, LLC Recent Developments
Table 81. Agena Bioscience, Inc Company Details
Table 82. Agena Bioscience, Inc Business Overview
Table 83. Agena Bioscience, Inc Cancer Genome Analysis Product
Table 84. Agena Bioscience, Inc Revenue in Cancer Genome Analysis Business (2017-2022) & (US$ Million)
Table 85. Agena Bioscience, Inc Recent Developments
Table 86. Agilent Company Details
Table 87. Agilent Business Overview
Table 88. Agilent Cancer Genome Analysis Product
Table 89. Agilent Revenue in Cancer Genome Analysis Business (2017-2022) & (US$ Million)
Table 90. Agilent Recent Developments
Table 91. Almac Diagnostics Company Details
Table 92. Almac Diagnostics Business Overview
Table 93. Almac Diagnostics Cancer Genome Analysis Product
Table 94. Almac Diagnostics Revenue in Cancer Genome Analysis Business (2017-2022) & (US$ Million)
Table 95. Almac Diagnostics Recent Developments
Table 96. Amoy Diagnostics Co., Ltd. Company Details
Table 97. Amoy Diagnostics Co., Ltd. Business Overview
Table 98. Amoy Diagnostics Co., Ltd. Cancer Genome Analysis Product
Table 99. Amoy Diagnostics Co., Ltd. Revenue in Cancer Genome Analysis Business (2017-2022) & (US$ Million)
Table 100. Amoy Diagnostics Co., Ltd. Recent Developments
Table 101. Anchor Dx Company Details
Table 102. Anchor Dx Business Overview
Table 103. Anchor Dx Cancer Genome Analysis Product
Table 104. Anchor Dx Revenue in Cancer Genome Analysis Business (2017-2022) & (US$ Million)
Table 105. Anchor Dx Recent Developments
Table 106. ANGLE plc Company Details
Table 107. ANGLE plc Business Overview
Table 108. ANGLE plc Cancer Genome Analysis Product
Table 109. ANGLE plc Revenue in Cancer Genome Analysis Business (2017-2022) & (US$ Million)
Table 110. ANGLE plc Recent Developments
Table 111. ApoCell, Inc. Company Details
Table 112. ApoCell, Inc. Business Overview
Table 113. ApoCell, Inc. Cancer Genome Analysis Product
Table 114. ApoCell, Inc. Revenue in Cancer Genome Analysis Business (2017-2022) & (US$ Million)
Table 115. ApoCell, Inc. Recent Developments
Table 116. ArcherDx, Inc Company Details
Table 117. ArcherDx, Inc Business Overview
Table 118. ArcherDx, Inc Cancer Genome Analysis Product
Table 119. ArcherDx, Inc Revenue in Cancer Genome Analysis Business (2017-2022) & (US$ Million)
Table 120. ArcherDx, Inc Recent Developments
Table 121. Asuragen Company Details
Table 122. Asuragen Business Overview
Table 123. Asuragen Cancer Genome Analysis Product
Table 124. Asuragen Revenue in Cancer Genome Analysis Business (2017-2022) & (US$ Million)
Table 125. Asuragen Recent Developments
Table 126. AVIVA Biosciences Company Details
Table 127. AVIVA Biosciences Business Overview
Table 128. AVIVA Biosciences Cancer Genome Analysis Product
Table 129. AVIVA Biosciences Revenue in Cancer Genome Analysis Business (2017-2022) & (US$ Million)
Table 130. AVIVA Biosciences Recent Developments
Table 131. Baylor Miraca Genetics Laboratories Company Details
Table 132. Baylor Miraca Genetics Laboratories Business Overview
Table 133. Baylor Miraca Genetics Laboratories Cancer Genome Analysis Product
Table 134. Baylor Miraca Genetics Laboratories Revenue in Cancer Genome Analysis Business (2017-2022) & (US$ Million)
Table 135. Baylor Miraca Genetics Laboratories Recent Developments
Table 136. Beckman Coulter, Inc. Company Details
Table 137. Beckman Coulter, Inc. Business Overview
Table 138. Beckman Coulter, Inc. Cancer Genome Analysis Product
Table 139. Beckman Coulter, Inc. Revenue in Cancer Genome Analysis Business (2017-2022) & (US$ Million)
Table 140. Beckman Coulter, Inc. Recent Developments
Table 141. Becton, Dickinson and Company Company Details
Table 142. Becton, Dickinson and Company Business Overview
Table 143. Becton, Dickinson and Company Cancer Genome Analysis Product
Table 144. Becton, Dickinson and Company Revenue in Cancer Genome Analysis Business (2017-2022) & (US$ Million)
Table 145. Becton, Dickinson and Company Recent Developments
Table 146. BGI Genomics Co. Ltd Company Details
Table 147. BGI Genomics Co. Ltd Business Overview
Table 148. BGI Genomics Co. Ltd Cancer Genome Analysis Product
Table 149. BGI Genomics Co. Ltd Revenue in Cancer Genome Analysis Business (2017-2022) & (US$ Million)
Table 150. BGI Genomics Co. Ltd Recent Developments
Table 151. Bioarray Genetics Company Details
Table 152. Bioarray Genetics Business Overview
Table 153. Bioarray Genetics Cancer Genome Analysis Product
Table 154. Bioarray Genetics Revenue in Cancer Genome Analysis Business (2017-2022) & (US$ Million)
Table 155. Bioarray Genetics Recent Developments
Table 156. Biocartis Company Details
Table 157. Biocartis Business Overview
Table 158. Biocartis Cancer Genome Analysis Product
Table 159. Biocartis Revenue in Cancer Genome Analysis Business (2017-2022) & (US$ Million)
Table 160. Biocartis Recent Developments
Table 161. Biocept, Inc Company Details
Table 162. Biocept, Inc Business Overview
Table 163. Biocept, Inc Cancer Genome Analysis Product
Table 164. Biocept, Inc Revenue in Cancer Genome Analysis Business (2017-2022) & (US$ Million)
Table 165. Biocept, Inc Recent Developments
Table 166. Biodesix Inc Company Details
Table 167. Biodesix Inc Business Overview
Table 168. Biodesix Inc Cancer Genome Analysis Product
Table 169. Biodesix Inc Revenue in Cancer Genome Analysis Business (2017-2022) & (US$ Million)
Table 170. Biodesix Inc Recent Developments
Table 171. BioFluidica Company Details
Table 172. BioFluidica Business Overview
Table 173. BioFluidica Cancer Genome Analysis Product
Table 174. BioFluidica Revenue in Cancer Genome Analysis Business (2017-2022) & (US$ Million)
Table 175. BioFluidica Recent Developments
Table 176. bioM?rieux Diagnostics Company Details
Table 177. bioM?rieux Diagnostics Business Overview
Table 178. bioM?rieux Diagnostics Cancer Genome Analysis Product
Table 179. bioM?rieux Diagnostics Revenue in Cancer Genome Analysis Business (2017-2022) & (US$ Million)
Table 180. bioM?rieux Diagnostics Recent Developments
Table 181. Bioneer Corporation Company Details
Table 182. Bioneer Corporation Business Overview
Table 183. Bioneer Corporation Cancer Genome Analysis Product
Table 184. Bioneer Corporation Revenue in Cancer Genome Analysis Business (2017-2022) & (US$ Million)
Table 185. Bioneer Corporation Recent Developments
Table 186. Bio-Rad Laboratories, Inc Company Details
Table 187. Bio-Rad Laboratories, Inc Business Overview
Table 188. Bio-Rad Laboratories, Inc Cancer Genome Analysis Product
Table 189. Bio-Rad Laboratories, Inc Revenue in Cancer Genome Analysis Business (2017-2022) & (US$ Million)
Table 190. Bio-Rad Laboratories, Inc Recent Developments
Table 191. Bio-Techne Company Details
Table 192. Bio-Techne Business Overview
Table 193. Bio-Techne Cancer Genome Analysis Product
Table 194. Bio-Techne Revenue in Cancer Genome Analysis Business (2017-2022) & (US$ Million)
Table 195. Bio-Techne Recent Developments
Table 196. Research Programs/Design for This Report
Table 197. Key Data Information from Secondary Sources
Table 198. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cancer Genome Analysis Market Share by Type: 2021 VS 2028
Figure 2. Solid Tissue Analysis Features
Figure 3. Liquid Tissue Analysis Features
Figure 4. Global Cancer Genome Analysis Market Share by Application: 2021 VS 2028
Figure 5. Clinical Case Studies
Figure 6. Pharmaceutical Case Studies
Figure 7. Research Case Studies
Figure 8. Cancer Genome Analysis Report Years Considered
Figure 9. Global Cancer Genome Analysis Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 10. Global Cancer Genome Analysis Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Cancer Genome Analysis Market Share by Region: 2021 VS 2028
Figure 12. Global Cancer Genome Analysis Market Share by Players in 2021
Figure 13. Global Top Cancer Genome Analysis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Genome Analysis as of 2021)
Figure 14. The Top 10 and 5 Players Market Share by Cancer Genome Analysis Revenue in 2021
Figure 15. North America Cancer Genome Analysis Market Size YoY (2017-2028) & (US$ Million)
Figure 16. North America Cancer Genome Analysis Market Size Market Share by Type (2017-2028)
Figure 17. North America Cancer Genome Analysis Market Size Market Share by Application (2017-2028)
Figure 18. North America Cancer Genome Analysis Market Size Share by Country (2017-2028)
Figure 19. United States Cancer Genome Analysis Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Canada Cancer Genome Analysis Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Europe Cancer Genome Analysis Market Size YoY (2017-2028) & (US$ Million)
Figure 22. Europe Cancer Genome Analysis Market Size Market Share by Type (2017-2028)
Figure 23. Europe Cancer Genome Analysis Market Size Market Share by Application (2017-2028)
Figure 24. Europe Cancer Genome Analysis Market Size Share by Country (2017-2028)
Figure 25. Germany Cancer Genome Analysis Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. France Cancer Genome Analysis Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. U.K. Cancer Genome Analysis Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Italy Cancer Genome Analysis Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Russia Cancer Genome Analysis Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Nordic Countries Cancer Genome Analysis Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Asia-Pacific Cancer Genome Analysis Market Size YoY (2017-2028) & (US$ Million)
Figure 32. Asia Pacific Cancer Genome Analysis Market Size Market Share by Type (2017-2028)
Figure 33. Asia Pacific Cancer Genome Analysis Market Size Market Share by Application (2017-2028)
Figure 34. Asia Pacific Cancer Genome Analysis Market Size Share by Region (2017-2028)
Figure 35. China Cancer Genome Analysis Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Japan Cancer Genome Analysis Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. South Korea Cancer Genome Analysis Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Southeast Asia Cancer Genome Analysis Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. India Cancer Genome Analysis Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Australia Cancer Genome Analysis Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 41. Latin America Cancer Genome Analysis Market Size YoY (2017-2028) & (US$ Million)
Figure 42. Latin America Cancer Genome Analysis Market Size Market Share by Type (2017-2028)
Figure 43. Latin America Cancer Genome Analysis Market Size Market Share by Application (2017-2028)
Figure 44. Latin America Cancer Genome Analysis Market Size Share by Country (2017-2028)
Figure 45. Mexico Cancer Genome Analysis Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 46. Brazil Cancer Genome Analysis Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 47. Middle East & Africa Cancer Genome Analysis Market Size YoY (2017-2028) & (US$ Million)
Figure 48. Middle East and Africa Cancer Genome Analysis Market Size Market Share by Type (2017-2028)
Figure 49. Middle East and Africa Cancer Genome Analysis Market Size Market Share by Application (2017-2028)
Figure 50. Middle East and Africa Cancer Genome Analysis Market Size Share by Country (2017-2028)
Figure 51. Turkey Cancer Genome Analysis Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 52. Saudi Arabia Cancer Genome Analysis Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 53. UAE Cancer Genome Analysis Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. Abbott Diagnostics Revenue Growth Rate in Cancer Genome Analysis Business (2017-2022)
Figure 55. AccuraGen Inc Revenue Growth Rate in Cancer Genome Analysis Business (2017-2022)
Figure 56. Acuamark Diagnostics Revenue Growth Rate in Cancer Genome Analysis Business (2017-2022)
Figure 57. Admera Health, LLC Revenue Growth Rate in Cancer Genome Analysis Business (2017-2022)
Figure 58. Agena Bioscience, Inc Revenue Growth Rate in Cancer Genome Analysis Business (2017-2022)
Figure 59. Agilent Revenue Growth Rate in Cancer Genome Analysis Business (2017-2022)
Figure 60. Almac Diagnostics Revenue Growth Rate in Cancer Genome Analysis Business (2017-2022)
Figure 61. Amoy Diagnostics Co., Ltd. Revenue Growth Rate in Cancer Genome Analysis Business (2017-2022)
Figure 62. Anchor Dx Revenue Growth Rate in Cancer Genome Analysis Business (2017-2022)
Figure 63. ANGLE plc Revenue Growth Rate in Cancer Genome Analysis Business (2017-2022)
Figure 64. ApoCell, Inc. Revenue Growth Rate in Cancer Genome Analysis Business (2017-2022)
Figure 65. ArcherDx, Inc Revenue Growth Rate in Cancer Genome Analysis Business (2017-2022)
Figure 66. Asuragen Revenue Growth Rate in Cancer Genome Analysis Business (2017-2022)
Figure 67. AVIVA Biosciences Revenue Growth Rate in Cancer Genome Analysis Business (2017-2022)
Figure 68. Baylor Miraca Genetics Laboratories Revenue Growth Rate in Cancer Genome Analysis Business (2017-2022)
Figure 69. Beckman Coulter, Inc. Revenue Growth Rate in Cancer Genome Analysis Business (2017-2022)
Figure 70. Becton, Dickinson and Company Revenue Growth Rate in Cancer Genome Analysis Business (2017-2022)
Figure 71. BGI Genomics Co. Ltd Revenue Growth Rate in Cancer Genome Analysis Business (2017-2022)
Figure 72. Bioarray Genetics Revenue Growth Rate in Cancer Genome Analysis Business (2017-2022)
Figure 73. Biocartis Revenue Growth Rate in Cancer Genome Analysis Business (2017-2022)
Figure 74. Biocept, Inc Revenue Growth Rate in Cancer Genome Analysis Business (2017-2022)
Figure 75. Biodesix Inc Revenue Growth Rate in Cancer Genome Analysis Business (2017-2022)
Figure 76. BioFluidica Revenue Growth Rate in Cancer Genome Analysis Business (2017-2022)
Figure 77. bioM?rieux Diagnostics Revenue Growth Rate in Cancer Genome Analysis Business (2017-2022)
Figure 78. Bioneer Corporation Revenue Growth Rate in Cancer Genome Analysis Business (2017-2022)
Figure 79. Bio-Rad Laboratories, Inc Revenue Growth Rate in Cancer Genome Analysis Business (2017-2022)
Figure 80. Bio-Techne Revenue Growth Rate in Cancer Genome Analysis Business (2017-2022)
Figure 81. Bottom-up and Top-down Approaches for This Report
Figure 82. Data Triangulation
Figure 83. Key Executives Interviewed

DOWNLOAD SAMPLE